News
  • No categories

A $430m exit for XtremIO

EMC Corporation announced that it has acquired Israeli storage systems firm, XtremIO. Widely regarded as one of the world’s premier Flash storage architecture pioneers, the American EMC paid $430 million to buy Herzliya-based XtremIO. XtremIO was founded in 2009 by …

Israel’s Macrocure stamps out diabetic foot ulcers

Israel’s Macrocure, a biotechnology company developing advanced cell therapy products, announced positive results for a “Real Life” Phase IV trial of its lead product, CureXcell, for the treatment of hard-to-heal ulcers in a community care setting. CureXcell is made with …

Israelis lead in social surfing

A whopping 91.5 percent of Israeli internet users over the age of 18 use social networks, according to a new survey by the Mahshov Research Institute. With Wi-Fi readily available around the country – and usually free of charge—it isn’t …

Israel’s AeroScout sold for $240m.

Israel’s AeroScout – a global leader in tracking objects and people through Wi-Fi networks – has reportedly been acquired by an American infrastructure and services company for some $240 million. The Calcalist business daily reported that the buyer will identify …

Gilad Shalit to lead peace ride

The annual ‘Cycling for Peace’ ride has come full circle as Gilad Shalit takes the lead in tomorrow’s event (May 4). Last year’s happening was dedicated to the release of Shalit, who was kidnapped by Hamas. This year, he’s set …

FDA approves Israeli-made Gaucher drug Elelyso

A new Israeli developed treatment for Gaucher disease is set to hit pharmacies around the globe, following approval of the new drug by the American Food and Drug Administration. The new medication is called Elelyso and it was developed by …

New HU research could help treat autism

Hebrew University of Jerusalem researchers have shown that the different genes involved in autism tend to be involved in specific processes in the brain. The scientists say their study has potential implications for early diagnosis as well as for treatment of autism in the future.

Brainsway raises $4.3 million

Brainsway raises $4.3 million

Following positive trial results in the treatment of major depression, Israel’s Brainsway has raised $4.3 million. The funding came from an allotment of shares and warrants to a group of investors led by the private equity fund, Shavit Capital. Brainsway has …